I can't understand how hiring of mr cole, a business development person, would have an impact on near term product revenue. How would hiring him cause an increase in 2q revenue. Will more patients have cancer?. Will the fda expand the label? Will doctors start prescribing more In Earlier lines? Please explain the claim that his hiring could have any direct impact in q2 product revenue.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.